Search Result "lipoprotein subfractions"
Effect of Fenofibrate on the Concentration and Relative Distribution of LDL Subfractions in Patients with Combined Dyslipidemia
Journal: Letters in Drug Design & Discovery
Volume: 1 Issue: 4 Year: 2004 Page: 380-383
Author(s): V. Tsimihodimos, M. Elisaf, A. Tselepis, A. Tambaki, E. Bairaktari
Subfractions and Subpopulations of HDL: An Update
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2881-2891
Author(s): M. Rizzo,J. Otvos,D. Nikolic,G. Montalto,P.P. Toth,M. Banach
Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 365-375
Author(s): Michal Kidawa,Anna Gluba-Brzózka,Marzenna Zielinska,Beata Franczyk,Maciej Banach,Jacek Rysz
LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6249-6255
Author(s): Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo, Ron C. Hoogeveen
High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 2 Year: 2017 Page: 144-151
Author(s): Magdalena Rysz-Gorzy nska, Anna Gluba-Brzozka, Maciej Banach
Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 2 Year: 2017 Page: 123-134
Author(s): Anna Gluba-Brzozka, Beata Franczyk, Piotr Bartnicki, Magdalena Rysz-Gorzyn ska, Jacek Rysz
Statins and Metabolism of High Density Lipoprotein
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2007 Page: 215-221
Author(s): Dmitri Sviridov, Paul Nestel, Gerald Watts
Modified and Dysfunctional Lipoproteins in Atherosclerosis: Effectors or Biomarkers?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1512-1524
Author(s): Alexander N. Orekhov,Igor A. Sobenin
Lipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up Study
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 298-305
Author(s): Magdalena Dusejovska,Barbora Stankova,Marek Vecka,Jana RychlÃkova,Magdalena Mokrejsova,Ivan RychlÃk,Ales Zak
Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 6 Year: 2010 Page: 820-830
Author(s): Matilda Florentin, Alexadros D. Tselepis, Moses S. Elisaf, Christos V. Rizos, Dimitri P. Mikhailidis, Evangelos N. Liberopoulos